WFC
REGN icon

Western Financial Corp’s Regeneron Pharmaceuticals REGN Stock Holding History

Western Financial Corp’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-870
Closed -$620K – 134
2024
Q4 		$620K Sell
870
-833
-49% -$699K 0.34% 77
2024
Q3 		$1.79M Sell
1,703
-116
-6% -$129K 1.02% 23
2024
Q2 		$1.91M Buy
1,819
+12
+0.7% +$11.6K 1.16% 17
2024
Q1 		$1.74M Buy
1,807
+132
+8% +$126K 1.07% 22
2023
Q4 		$1.47M Sell
1,675
-81
-5% -$66.7K 0.98% 18
2023
Q3 		$1.45M Sell
1,756
-22
-1% -$17.3K 1.06% 17
2023
Q2 		$1.28M Buy
1,778
+14
+0.8% +$10.8K 0.87% 24
2023
Q1 		$1.45M Buy
1,764
+129
+8% +$97.3K 1.03% 13
2022
Q4 		$1.18M Buy
1,635
+672
+70% +$496K 0.76% 22
2022
Q3 		$663K Buy
963
+193
+25% +$121K 0.46% 48
2022
Q2 		$455K Buy
+770
New +$501K 0.32% 69

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Western Financial Corp's REGN Position: Q1 2025 in Review

Western Financial Corp sold out of Regeneron Pharmaceuticals (REGN) in Q1 2025, closing a stake of 870 shares — an estimated $620K sold.

Western Financial Corp first reported a position in REGN in Q2 2022 and held it in 11 quarters. The position peaked at $1.91M in Q2 2024. 1,292 funds tracked by Wall St. Rank hold REGN as of Q1 2025.

  • Western Financial Corp reported no remaining Regeneron Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Western Financial Corp sold 870 Regeneron Pharmaceuticals shares in Q1 2025, an estimated $620K.
  • Western Financial Corp first reported a position in Regeneron Pharmaceuticals in Q2 2022 and held it in 11 quarters.
  • Western Financial Corp's Regeneron Pharmaceuticals position peaked at $1.91M in Q2 2024.
  • 1,292 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2025.

Based on Western Financial Corp's 13F filing for Q1 2025, filed 23 Apr 2025.